Fexofenadine Hydrochloride Patent Expiration
Fexofenadine Hydrochloride is used for treating respiratory allergies, hives (urticaria), and their associated symptoms in adults and children. It was first introduced by Chattem Inc Dba Sanofi Consumer Healthcare
Fexofenadine Hydrochloride Patents
Given below is the list of patents protecting Fexofenadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Allegra | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US5738872 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Allergy | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Allergy | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Hives | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Hives | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US6723348 | Orodispersible tablets containing fexofenadine |
Nov 26, 2021
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US8933097 | Fexofenadine suspension formulation | Aug 02, 2030 | Chattem Sanofi |
| Children's Allegra Hives | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6723348 | Orodispersible tablets containing fexofenadine |
Nov 26, 2021
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US8933097 | Fexofenadine suspension formulation | Aug 02, 2030 | Chattem Sanofi |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Fexofenadine Hydrochloride Generics
Several generic applications have been filed for Fexofenadine Hydrochloride. The first generic version for Fexofenadine Hydrochloride was by Barr Laboratories Inc and was approved on Jul 13, 2005. And the latest generic version is by Aurobindo Pharma Ltd and was approved on May 23, 2023.
Given below is the list of companies who have filed for Fexofenadine Hydrochloride generic.
1. WOCKHARDT
Wockhardt Ltd has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES, 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet | Over the counter | ORAL | N/A | Feb 8, 2012 |
| 60MG | tablet | Over the counter | ORAL | N/A | Feb 8, 2012 |
| 180MG | tablet | Over the counter | ORAL | N/A | Feb 8, 2012 |
2. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Fexofenadine Hydrochloride. This 30mg/5ml version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG/5ML | suspension | Over the counter | ORAL | N/A | Nov 9, 2017 |
3. RISING
Rising Pharma Holdings Inc has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES, 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES, 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | tablet | Over the counter | ORAL | N/A | Jul 21, 2011 |
| 60MG | tablet | Over the counter | ORAL | N/A | Jul 21, 2011 |
| 30MG | tablet | Discontinued | ORAL | N/A | Jul 21, 2011 |
4. L PERRIGO CO
L Perrigo Co has filed for 2 different strengths of generic version for Fexofenadine Hydrochloride. Given below are the details of the strengths of this generic introduced by L Perrigo Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Over the counter | ORAL | N/A | Feb 24, 2020 |
| 180MG | tablet | Over the counter | ORAL | N/A | Feb 24, 2020 |
5. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Jan 18, 2013 |
| 180MG | tablet | Over the counter | ORAL | N/A | Apr 12, 2011 |
| 60MG | tablet | Over the counter | ORAL | N/A | Apr 12, 2011 |
6. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Discontinued | ORAL | N/A | Feb 6, 2012 |
| 180MG | tablet | Over the counter | ORAL | N/A | Feb 6, 2012 |
| 30MG | tablet | Discontinued | ORAL | N/A | Feb 6, 2012 |
7. BARR
Barr Laboratories Inc has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Discontinued | ORAL | N/A | Aug 31, 2005 |
| 180MG | tablet | Discontinued | ORAL | N/A | Aug 31, 2005 |
| 30MG | tablet | Discontinued | ORAL | N/A | Aug 31, 2005 |
8. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES, 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE HIVES, 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Over the counter | ORAL | N/A | Apr 13, 2011 |
| 180MG | tablet | Over the counter | ORAL | N/A | Apr 13, 2011 |
| 30MG | tablet | Over the counter | ORAL | N/A | Apr 13, 2011 |
9. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | tablet | Over the counter | ORAL | N/A | Nov 19, 2014 |
| 30MG | tablet | Over the counter | ORAL | N/A | Nov 19, 2014 |
| 60MG | tablet | Over the counter | ORAL | N/A | Nov 19, 2014 |
| 30MG/5ML | suspension | Over the counter | ORAL | N/A | May 23, 2023 |
10. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Fexofenadine Hydrochloride. Out of these 60mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY, 30mg version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Over the counter | ORAL | N/A | Aug 19, 2016 |
| 180MG | tablet | Over the counter | ORAL | N/A | Aug 19, 2016 |
| 30MG | tablet | Over the counter | ORAL | N/A | Aug 19, 2016 |
11. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Fexofenadine Hydrochloride. All of these versions come by the name FEXOFENADINE HYDROCHLORIDE HIVES. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Over the counter | ORAL | N/A | Sep 16, 2015 |
| 180MG | tablet | Over the counter | ORAL | N/A | Sep 16, 2015 |
12. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 1 generic for Fexofenadine Hydrochloride. This 180mg version comes by the name FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Unique.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 180MG | tablet | Over the counter | ORAL | N/A | Aug 13, 2018 |
13. P AND L
P And L Development Llc has filed for 1 generic for Fexofenadine Hydrochloride. This 30mg/5ml version comes by the name CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG/5ML | suspension | Over the counter | ORAL | N/A | Nov 18, 2014 |
14. GRANULES
Granules India Ltd has filed for 2 different strengths of generic version for Fexofenadine Hydrochloride. All of these versions come by the name FEXOFENADINE HYDROCHLORIDE ALLERGY. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Over the counter | ORAL | N/A | Oct 18, 2019 |
| 180MG | tablet | Over the counter | ORAL | N/A | Oct 18, 2019 |